Gw Pharma ADR (GWPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 458,101 | 486,752 | 480,330 | 477,557 | 500,935 |
| Receivables | 84,947 | 71,168 | 80,424 | 80,357 | 62,209 |
| Inventories | 137,627 | 129,138 | 115,036 | 99,620 | 89,056 |
| TOTAL | $718,733 | $729,530 | $720,275 | $687,717 | $672,746 |
| Non-Current Assets | |||||
| PPE Net | 149,591 | 143,767 | 131,204 | 125,106 | 122,882 |
| Intangibles | 12,230 | 12,524 | 12,523 | 12,586 | 12,910 |
| Other Non-Current Assets | 53,789 | 53,690 | 46,259 | 45,171 | 45,839 |
| TOTAL | $215,610 | $209,981 | $189,986 | $182,863 | $181,631 |
| Total Assets | $934,343 | $939,511 | $910,261 | $870,580 | $854,377 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 16,672 | 21,870 | 17,841 | 16,238 | 18,345 |
| Accrued Expenses | 136,101 | 127,849 | 114,898 | 93,313 | 77,479 |
| Other current liabilities | 7,053 | 9,210 | 7,549 | 6,947 | 6,650 |
| TOTAL | $160,246 | $159,806 | $140,288 | $118,502 | $103,472 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 32,311 | 33,161 | 30,306 | 30,075 | 30,743 |
| TOTAL | $37,724 | $38,615 | $35,525 | $35,141 | $35,900 |
| Total Liabilities | $197,970 | $198,421 | $175,813 | $153,643 | $139,372 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 31,545 | 31,349 | 31,182 | 31,143 | 31,080 |
| Common Shares | 583 | 577 | 575 | 575 | 573 |
| Retained earnings | -915,764 | -896,087 | -866,940 | -854,752 | -845,924 |
| Other shareholders' equity | -51,024 | -53,551 | -71,424 | -84,386 | -83,051 |
| TOTAL | $736,373 | $741,090 | $734,448 | $716,937 | $715,005 |
| Total Liabilities And Equity | $934,343 | $939,511 | $910,261 | $870,580 | $854,377 |